Center for Biophysics and Quantitative Biology Master Calendar
84 matches found
-
John Glass, PhD J. Craig Venter Institute; Professor and Leader of the Synthetic Biology & Bioenergy Group
-
There are significant concerns about the reproducibility of scientific results across many fields including neuroimaging. This talk will discuss the source of these problems and outline a set of approaches to improve the reproducibility of neuroimaging research.
-
"Even a Moon Shot Needs a Flight Plan: Genetics and Ethics in the Obama Administration" Dr. Alondra Nelson President, Social Science Research Council Harold F. Linder Professor, Institute for Advanced Study, Princeton
-
The metastatic spread of tumors to distant organs is responsible for more than 90% of cancer-related deaths. Malignant cells that detach from a primary tumor and spread through the bloodstream are called circulating tumor cells (CTCs). Analysis of CTCs collected from blood holds promise as a repeatable and minimally invasive alternative for tissue biopsies. However, widesp
-
CHEM 575 Literature Seminar
-
Jay Keasling, PhD University of California Berkeley College of Chemistry; Professor, Department of Chemical & Biomolecular Engineering and Professor, Department of Bioengineering
-
Antibodies act as a nexus between innate and adaptive immunity: they provide a means to target the potent toxic activities of a spectrum of innate immune effector cells in order to clear viral particles and infected cells. This functional landscape is remarkably complex, with multiple antibody variants directed to multiple epitopes on multiple viral antigens. This diversit
-
The event will recognize recipients of the Chemical and Biomolecular Engineering Alumni Awards and graduate students who have won fellowships. 4 p.m.: Ceremony 5 p.m.: Reception
-
Converging Paths: My Career as a Scientist and an Entrepreneur Monday, October 14th at 12:00pm in 612 IGB Dr. Penelope Shihab CEO and Founder, Monojo Biotech; Skinue.com; Applied Scientific Research Fund
-
Fox Family Innovation and Entrepreneurship Lecture "Turning Science Into Social Impact: How We Built A Computational Genomics Operating System for Treating Cancer" Kevin White, PhD President of Tempus Labs Inc.; Professor, Department of Human Genetics and Medicine, University of Chicago
-
The last few years has seen rapid progress in the discovery of genes underlying risk for severe mental illness, Research in the Ament lab aims to trace mechanisms from genes to brain to mental illness through human genetics, stem cell models of brain development, and single-cell genomics.
-
CHEM 575 Literature Seminar
-
The Graduate Research Symposium allows graduate students to present their work in the form of either a poster or an oral presentation. Research areas include a range of topics. Judges are alumni from industry and academia.
-
John F. Allen Research Department of Genetics, Evolution and Environment University College London "Why have chloroplasts and mitochondria retained genomes?"
-
"Genetic Studies of Autism Spectrum Disorders: Family-based Approach" Maja Bucan, PhD University of Pennsylvania Perelman School of Medicine; Professor, Department of Genetics
-
Dr. Miller will discuss results from his study of pre-clinical Alzhimer's disease as part of the BIOCARD project. We will examine the central technologies of Computational Anatomy based on diffeomorphometry for quantifying the anatomical structures of 3T clinical MRI at 1 millimeter scale.
-
“Life Innovates, Biology Integrates: A Vision for the Biological Sciences” Dr. Joanne Tornow Assistant Director for Biological Sciences, National Science Foundation Reception immediately following, sponsored by the Catherine and Don Kleinmuntz Center for Genomics in Business and Society
-
CHEM 575 Literature Seminar
-
Reception immediately following in 'A' Atrium of CLSL
-
Trudy Mackay, PhD Clemson University; Professor, Department of Genetics and Biochemistry
-
There has been a surge in technologies to observe how genes and proteins change in the brain during disease. I will describe a new method, DART (drugs acutely restricted by tethering), to rapidly restrict drugs to genetically defined neurons in behaving mice. The approach offers a new way to establish causal circuit and molecular substrates of normal and aberrant behavior.
-
Microbial strains have been successfully engineered to produce a wide variety of chemical compounds, several of which have been commercialized. As new products are targeted for biological synthesis, yield is frequently considered a primary driver towards determining feasibility. Theoretical yields can be calculated, establishing an upper limit on the potential conversion
-
"The Antimicrobial Resistance Crisis: How NIAMRRE Supports Solutions" Dr. Kristen Obbink, DVM, MPH Associate Director, National Institute of Antimicrobial Resistance Research and Education (NIAMRRE), Iowa State University
-
CHEM 575 Literature Seminar
